Cargando…
Metformin as an anticancer drug: A Commentary on the metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Autores principales: | Song, In-Sung, Han, Jin, Lee, Hong Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578488/ https://www.ncbi.nlm.nih.gov/pubmed/26421142 http://dx.doi.org/10.1111/jdi.12300 |
Ejemplares similares
-
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
por: Birsoy, Kıvanç, et al.
Publicado: (2014) -
Regulatory Effects of Metformin, an Antidiabetic Biguanide Drug, on the Metabolism of Primary Rat Adipocytes
por: Szkudelski, Tomasz, et al.
Publicado: (2022) -
Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria
por: Bridges, Hannah R., et al.
Publicado: (2014) -
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin
por: Laustriat, Delphine, et al.
Publicado: (2015) -
Metformin (dimethyl-biguanide) induced DNA damage in mammalian cells
por: Amador, Rubem R., et al.
Publicado: (2012)